Purple Biotech
Price & Volume
Stats
See more52W Range | $1.42-$29 |
Market Cap | $1.6M |
Shares Short | 49,071 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$59,000 |
Diluted EPS | $3,226 |
News
See moreYahoo Finance • 3 months ago
Purple Biotech Regains Compliance with Nasdaq
Yahoo Finance • 7 months ago
Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress
Yahoo Finance • 7 months ago
Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update
Yahoo Finance • 8 months ago
Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform
About
CEO | Mr. Gil Efron CPA, M.A. |
Address | 4 Oppenheimer Street, Rehovot, Israel, 7670104 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 10 |